Drugs affecting lipid metabolism:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Dordrecht [u.a.]
Kluwer Acad. Publ.
1993
|
| Schriftenreihe: | Medical science symposia series
2 |
| Schlagworte: | |
| Beschreibung: | XX, 520 S. Ill., graph. Darst. |
| ISBN: | 0792322320 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV008841022 | ||
| 003 | DE-604 | ||
| 005 | 20021203 | ||
| 007 | t | ||
| 008 | 940117s1993 ad|| |||| 10||| eng d | ||
| 020 | |a 0792322320 |9 0-7923-2232-0 | ||
| 035 | |a (OCoLC)28337734 | ||
| 035 | |a (DE-599)BVBBV008841022 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 |a DE-19 |a DE-188 | ||
| 050 | 0 | |a RC632.H87 | |
| 082 | 0 | |a 615/.739 |2 20 | |
| 084 | |a XI 4905 |0 (DE-625)153009:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Drugs affecting lipid metabolism |c ed. by A. L. Catapano ... |
| 264 | 1 | |a Dordrecht [u.a.] |b Kluwer Acad. Publ. |c 1993 | |
| 300 | |a XX, 520 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Medical science symposia series |v 2 | |
| 650 | 2 | |a Antilipémiants - Congrès comme sujet | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Lipiden |2 gtt | |
| 650 | 2 | |a Lipides - Métabolisme - Congrès comme sujet | |
| 650 | 2 | |a Lipoprotéines - Métabolisme - Congrès comme sujet | |
| 650 | 2 | |a Métabolisme - action des médicaments et substances chimiques - Congrès comme sujet | |
| 650 | 7 | |a Stofwisseling |2 gtt | |
| 650 | 4 | |a Antilipemic Agents |v Congresses | |
| 650 | 4 | |a Antilipemic agents |v Congresses | |
| 650 | 4 | |a Atherosclerosis |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Coronary heart disease |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Hyperlipidemia |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Lipid Metabolism |v Congresses | |
| 650 | 4 | |a Lipoproteins |x metabolism |v Congresses | |
| 650 | 4 | |a Metabolism |x drug effects |v Congresses | |
| 650 | 0 | 7 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hyperlipidämie |0 (DE-588)4161072-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Lipidsenker |0 (DE-588)4167796-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Atherogenese |0 (DE-588)4195269-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1992 |z Florenz |2 gnd-content | |
| 689 | 0 | 0 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Lipidstoffwechselstörung |0 (DE-588)4035876-8 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 3 | 1 | |a Atherogenese |0 (DE-588)4195269-8 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Lipidsenker |0 (DE-588)4167796-1 |D s |
| 689 | 4 | |5 DE-188 | |
| 689 | 5 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 5 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 5 | |5 DE-188 | |
| 700 | 1 | |a Catapano, Alberico L. |e Sonstige |4 oth | |
| 830 | 0 | |a Medical science symposia series |v 2 |w (DE-604)BV008340509 |9 2 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005846042 | ||
Datensatz im Suchindex
| _version_ | 1804123194361118721 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV008841022 |
| callnumber-first | R - Medicine |
| callnumber-label | RC632 |
| callnumber-raw | RC632.H87 |
| callnumber-search | RC632.H87 |
| callnumber-sort | RC 3632 H87 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 4905 |
| ctrlnum | (OCoLC)28337734 (DE-599)BVBBV008841022 |
| dewey-full | 615/.739 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.739 |
| dewey-search | 615/.739 |
| dewey-sort | 3615 3739 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03094nam a2200793 cb4500</leader><controlfield tag="001">BV008841022</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20021203 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940117s1993 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792322320</subfield><subfield code="9">0-7923-2232-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)28337734</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008841022</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC632.H87</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.739</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4905</subfield><subfield code="0">(DE-625)153009:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs affecting lipid metabolism</subfield><subfield code="c">ed. by A. L. Catapano ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht [u.a.]</subfield><subfield code="b">Kluwer Acad. Publ.</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 520 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Medical science symposia series</subfield><subfield code="v">2</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antilipémiants - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipiden</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Lipides - Métabolisme - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Lipoprotéines - Métabolisme - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Métabolisme - action des médicaments et substances chimiques - Congrès comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stofwisseling</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic Agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Atherosclerosis</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Coronary heart disease</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hyperlipidemia</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid Metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipoproteins</subfield><subfield code="x">metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolism</subfield><subfield code="x">drug effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Atherogenese</subfield><subfield code="0">(DE-588)4195269-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1992</subfield><subfield code="z">Florenz</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Lipidstoffwechselstörung</subfield><subfield code="0">(DE-588)4035876-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Atherogenese</subfield><subfield code="0">(DE-588)4195269-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Catapano, Alberico L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Medical science symposia series</subfield><subfield code="v">2</subfield><subfield code="w">(DE-604)BV008340509</subfield><subfield code="9">2</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005846042</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1992 Florenz gnd-content |
| genre_facet | Konferenzschrift 1992 Florenz |
| id | DE-604.BV008841022 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:25:54Z |
| institution | BVB |
| isbn | 0792322320 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005846042 |
| oclc_num | 28337734 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 DE-19 DE-BY-UBM DE-188 |
| owner_facet | DE-355 DE-BY-UBR DE-12 DE-19 DE-BY-UBM DE-188 |
| physical | XX, 520 S. Ill., graph. Darst. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Kluwer Acad. Publ. |
| record_format | marc |
| series | Medical science symposia series |
| series2 | Medical science symposia series |
| spelling | Drugs affecting lipid metabolism ed. by A. L. Catapano ... Dordrecht [u.a.] Kluwer Acad. Publ. 1993 XX, 520 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Medical science symposia series 2 Antilipémiants - Congrès comme sujet Geneesmiddelen gtt Lipiden gtt Lipides - Métabolisme - Congrès comme sujet Lipoprotéines - Métabolisme - Congrès comme sujet Métabolisme - action des médicaments et substances chimiques - Congrès comme sujet Stofwisseling gtt Antilipemic Agents Congresses Antilipemic agents Congresses Atherosclerosis Chemotherapy Congresses Coronary heart disease Chemotherapy Congresses Hyperlipidemia Chemotherapy Congresses Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechselstörung (DE-588)4035876-8 gnd rswk-swf Lipidstoffwechsel (DE-588)4035875-6 gnd rswk-swf Hyperlipidämie (DE-588)4161072-6 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Lipidsenker (DE-588)4167796-1 gnd rswk-swf Atherogenese (DE-588)4195269-8 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1992 Florenz gnd-content Lipidstoffwechsel (DE-588)4035875-6 s Pharmakologie (DE-588)4045687-0 s DE-604 Hyperlipidämie (DE-588)4161072-6 s Pharmakotherapie (DE-588)4076066-2 s Lipidstoffwechselstörung (DE-588)4035876-8 s Atherogenese (DE-588)4195269-8 s Lipidsenker (DE-588)4167796-1 s DE-188 Chemotherapie (DE-588)4127083-6 s Catapano, Alberico L. Sonstige oth Medical science symposia series 2 (DE-604)BV008340509 2 |
| spellingShingle | Drugs affecting lipid metabolism Medical science symposia series Antilipémiants - Congrès comme sujet Geneesmiddelen gtt Lipiden gtt Lipides - Métabolisme - Congrès comme sujet Lipoprotéines - Métabolisme - Congrès comme sujet Métabolisme - action des médicaments et substances chimiques - Congrès comme sujet Stofwisseling gtt Antilipemic Agents Congresses Antilipemic agents Congresses Atherosclerosis Chemotherapy Congresses Coronary heart disease Chemotherapy Congresses Hyperlipidemia Chemotherapy Congresses Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechselstörung (DE-588)4035876-8 gnd Lipidstoffwechsel (DE-588)4035875-6 gnd Hyperlipidämie (DE-588)4161072-6 gnd Chemotherapie (DE-588)4127083-6 gnd Lipidsenker (DE-588)4167796-1 gnd Atherogenese (DE-588)4195269-8 gnd Pharmakologie (DE-588)4045687-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| subject_GND | (DE-588)4035876-8 (DE-588)4035875-6 (DE-588)4161072-6 (DE-588)4127083-6 (DE-588)4167796-1 (DE-588)4195269-8 (DE-588)4045687-0 (DE-588)4076066-2 (DE-588)1071861417 |
| title | Drugs affecting lipid metabolism |
| title_auth | Drugs affecting lipid metabolism |
| title_exact_search | Drugs affecting lipid metabolism |
| title_full | Drugs affecting lipid metabolism ed. by A. L. Catapano ... |
| title_fullStr | Drugs affecting lipid metabolism ed. by A. L. Catapano ... |
| title_full_unstemmed | Drugs affecting lipid metabolism ed. by A. L. Catapano ... |
| title_short | Drugs affecting lipid metabolism |
| title_sort | drugs affecting lipid metabolism |
| topic | Antilipémiants - Congrès comme sujet Geneesmiddelen gtt Lipiden gtt Lipides - Métabolisme - Congrès comme sujet Lipoprotéines - Métabolisme - Congrès comme sujet Métabolisme - action des médicaments et substances chimiques - Congrès comme sujet Stofwisseling gtt Antilipemic Agents Congresses Antilipemic agents Congresses Atherosclerosis Chemotherapy Congresses Coronary heart disease Chemotherapy Congresses Hyperlipidemia Chemotherapy Congresses Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechselstörung (DE-588)4035876-8 gnd Lipidstoffwechsel (DE-588)4035875-6 gnd Hyperlipidämie (DE-588)4161072-6 gnd Chemotherapie (DE-588)4127083-6 gnd Lipidsenker (DE-588)4167796-1 gnd Atherogenese (DE-588)4195269-8 gnd Pharmakologie (DE-588)4045687-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd |
| topic_facet | Antilipémiants - Congrès comme sujet Geneesmiddelen Lipiden Lipides - Métabolisme - Congrès comme sujet Lipoprotéines - Métabolisme - Congrès comme sujet Métabolisme - action des médicaments et substances chimiques - Congrès comme sujet Stofwisseling Antilipemic Agents Congresses Antilipemic agents Congresses Atherosclerosis Chemotherapy Congresses Coronary heart disease Chemotherapy Congresses Hyperlipidemia Chemotherapy Congresses Lipid Metabolism Congresses Lipoproteins metabolism Congresses Metabolism drug effects Congresses Lipidstoffwechselstörung Lipidstoffwechsel Hyperlipidämie Chemotherapie Lipidsenker Atherogenese Pharmakologie Pharmakotherapie Konferenzschrift 1992 Florenz |
| volume_link | (DE-604)BV008340509 |
| work_keys_str_mv | AT catapanoalbericol drugsaffectinglipidmetabolism |